Related by context. All words. (Click for frequent words.) 74 EGFR gene 68 CCL#L# 68 SMN2 gene 67 somatic mutations 67 TMPRSS2 ERG fusion 67 HER2 expression 67 F#del mutation 66 gene amplification 66 HER2 receptor 65 KRAS oncogene 65 chromosomal aberrations 65 TOP2A 65 WT1 65 HER2 protein 65 Wwox 64 HER2/neu 64 EGFR pathway 64 KRAS mutation 64 EGFR protein 64 Her2 gene 64 GSTP1 64 K ras mutations 64 Immunohistochemical analysis 64 variant allele 64 breast carcinoma 64 HFE gene 64 HER2 64 PIK3CA 64 Her2 63 somatic mutation 63 UGT#A# * 63 micrometastases 63 TGFBR1 * 6A 63 PTEN gene 63 SPINK1 63 HER2 positive cancers 63 methylated DNA 63 EGFR mutation 63 mesothelin 63 immunohistochemical 63 cisplatin resistant 63 miRNA genes 63 FGFR2 63 genomic alterations 63 thyroglobulin 63 CYP#D# gene 63 ERCC1 63 TOP2A gene 63 EGFRvIII 63 E#F# 63 FLT3 62 AGTR1 62 immunohistochemical analysis 62 K ras gene 62 number variations CNVs 62 microRNA expression 62 OGG1 62 squamous cell lung cancer 62 microdeletions 62 NSCLC tumors 62 epithelial ovarian cancer 62 PARP inhibition 62 nodal metastasis 62 MAPK pathway 62 mutant genes 62 Her2/neu 62 CFTR gene 62 BRAF mutation 62 IGF IR 62 autoantibodies 62 BRAF V#E mutation 62 mRNA transcripts 62 PCa 62 tumor specific antigen 62 HMGCR 61 urothelial carcinoma 61 RASSF1A 61 BRCA1 BRCA2 61 HbF 61 hypermethylated 61 GPC5 61 breast cancer metastasis 61 clusterin 61 micrometastasis 61 mutated K ras 61 prostate cancer CaP 61 CALHM1 61 BRAF gene 61 tumorigenicity 61 precursor lesions 61 breast carcinomas 61 miRNA expression 61 TMPRSS2 ERG 61 chlamydial infection 61 SMN2 61 transgene expression 61 T#I [002] 61 VKORC1 61 MAGE A3 61 mtDNA mutations 61 BRAF mutations 61 K#N 61 BRCA1 gene 61 NFKBIA 61 neuroblastoma tumors 61 HER2 overexpression 61 MIF protein 61 pituitary adenomas 61 Clusterin 61 Foxp3 61 BRCA2 mutation carriers 61 pDCs 61 STAT4 61 Lymph node 61 histopathologic examination 61 PTPN# 61 PALB2 61 promoter hypermethylation 61 TTR gene 61 TAp# 61 HPV# 61 KRAS status 61 splice variants 61 MSH2 61 EUS FNA 61 JAK2 enzyme 61 synovial tissue 61 APTIMA HPV 61 invasive carcinoma 61 axillary lymph nodes 61 UGT#A# 61 ELISPOT assay 61 HMGA2 60 miR #a [002] 60 EGFR receptor 60 VEGF receptor 60 NF1 gene 60 HER2 neu 60 microsatellite instability 60 genomewide 60 genomic loci 60 S#A# [002] 60 ASCUS 60 FGFR4 60 allelic 60 endostatin 60 miRNA molecules 60 PrPSc 60 KRAS mutations 60 CIN2 + 60 p# mutation 60 epithelial tumors 60 oncoprotein 60 glutamic acid decarboxylase 60 metastatic melanomas 60 chemoresistant 60 EGF receptors 60 gene rearrangements 60 cytolytic 60 LRP5 60 Epidermal Growth Factor Receptor 60 ABCB1 60 p# mutations 60 activin 60 TLE3 60 FGFR2 gene 60 lymph node biopsies 60 UGT#B# 60 lymph node metastasis 60 neutralizing antibody 60 p# biomarker 60 PDGFRA 60 chemokine receptor 60 number variation CNV 60 NRG1 60 HER2 positivity 60 beta1 integrin 60 GNAQ 60 SOD1 gene 60 Akt1 60 ERBB2 60 uPAR 60 TNFα 60 HPV subtypes 60 progesterone receptor 60 promoter methylation 60 MC1R gene 60 APOE e4 60 ADAM# 60 virulence genes 60 microRNA molecules 60 gastrointestinal stromal tumors GISTs 60 CEACAM1 60 IgG antibody 60 CD4 + lymphocytes 60 FGFs 60 chlamydial 60 CYP#C# [001] 60 TET2 59 methylation markers 59 melanoma tumors 59 PCA3 gene 59 GISTs 59 histological subtype 59 Pten gene 59 tumor biopsies 59 estrogen receptor ER 59 pCR 59 low expressors 59 FISH fluorescence 59 MECP2 gene 59 tumor subtypes 59 estrogen receptor 59 antisense RNA 59 colorectal tumor 59 Ets2 59 BCR ABL mutations 59 RRM1 59 Immunohistochemical staining 59 IL#B 59 HERmark assay 59 BDNF gene 59 invasive lobular 59 HAAH 59 advanced adenomas 59 kinase gene 59 breast cancer genes BRCA1 59 leukemic cell 59 trophoblast cells 59 NPM1 mutations 59 axillary nodes 59 viral genomes 59 HER-2/neu 59 miR #b [002] 59 BRAF protein 59 Wnt signaling pathway 59 NF kB pathway 59 prognostic marker 59 prostate carcinoma 59 IGF 1R 59 Prostate Specific Antigen PSA 59 metastatic lymph nodes 59 BARD1 59 single nucleotide polymorphism 59 activating mutations 59 immunostaining 59 MTHFR 59 TYMS 59 aneuploidy 59 MYCN 59 biologic pathways 59 vimentin 59 malignant ovarian 59 peptide antigens 59 BRCA deficient 59 granzyme B 59 HCV replicon 59 prognostic markers 59 miRview ™ squamous 59 K ras 59 CDK4 59 TSLP 59 aT cell 59 eIF 4E 59 GBM tumors 59 aneuploidies 59 HLA DQ2 59 iNOS 59 hormone receptor negative 59 interferon gamma 59 EphA2 59 renal cell carcinomas 59 VHL gene 59 hCG Beta 59 B7 H3 59 N Myc 59 HER2 positive tumors 59 nested PCR 59 receptor tyrosine kinase 59 distant metastasis 59 sentinel nodes 59 IgA deficiency 59 sentinel node 59 TCF#L# 59 EGFR 59 androgen receptor AR 59 #F FDG 59 pathogenic mutations 59 HLA B# 59 TRAIL induced apoptosis 59 HBsAg 59 proto oncogene 59 CDKN2A 58 RT qPCR 58 MGMT gene 58 follicle stimulating hormone 58 chemopreventive agent 58 EGFR mutations 58 ovarian tumors 58 hTERT 58 BCL#A 58 urine cytology 58 KRAS gene 58 susceptibility loci 58 advanced neoplasia 58 ABL1 58 ADPKD 58 Foxp2 58 Li Fraumeni 58 endocrine therapies 58 HER3 58 colorectal cancer CRC 58 prognostic indicator 58 androgen receptor gene 58 LRRK2 gene 58 gamma globin gene 58 abnormal cytology 58 ALK mutations 58 MSMB 58 TP# gene 58 grade cervical intraepithelial 58 COX2 58 colon tumors 58 genetic biomarkers 58 Treg cell 58 K ras mutation 58 germline mutations 58 HepG2 cells 58 leukemic cells 58 chemosensitivity 58 bladder tumors 58 Stat5 58 atypical hyperplasia 58 Aurora kinase 58 Immunohistochemistry 58 tumor hypoxia 58 cyclin E 58 tumor suppressor gene 58 neoadjuvant therapy 58 H#K#me# 58 messenger RNAs mRNAs 58 MMP9 58 EZH2 58 beta globin gene 58 APOL1 58 benign moles 58 fine needle aspiration 58 APOC3 58 BRCA1 mutation carriers 58 Akt activation 58 pelvic ultrasound 58 mammaglobin 58 atypical ductal hyperplasia 58 huntingtin gene 58 PC3 cells 58 TCF#L# gene 58 molecular abnormalities 58 PCA3 58 para aortic 58 EGF receptor 58 antitumor effect 58 pre malignant lesions 58 co stimulatory molecules 58 MUC1 protein 58 mRNA expression 58 microRNAs miRNAs 58 serum IgE 58 epigenetic markers 58 SNP rs# [001] 58 lymph node metastases 58 nonmelanoma skin cancers 58 SOX9 58 S#K# 58 breast cancer subtypes 58 splice junctions 58 malignant transformation 58 FGFR1 58 prostate specific 58 EphB2 58 Oncotype DX colon cancer 58 hedgehog pathway 58 poly ADP ribose polymerase 58 CCR5 mutation 58 genetic variants associated 58 percutaneous biopsy 58 ependymomas 58 DHFR 58 MGd 58 EGFR inhibitors 58 tumor antigen 58 #q#.# [001] 58 specific antigen 58 serum thyroglobulin 58 C#Y 58 somatostatin receptors 58 Gleevec resistant 58 NF kappaB activation 58 methylation patterns 58 biologic pathway 58 micro RNAs 58 hyperplastic 58 shRNAs 58 antibody titer 58 PCNSL 58 mitochondrial toxicity 58 malignant nodules 58 survivin 58 MC4R gene 58 transgenic mouse model 58 murine models 58 cardiac troponin T 58 advanced adenoma 58 differentiated thyroid 58 mRNA molecules 58 LHRH receptor positive 58 3'UTR 58 FUS1 58 eotaxin 58 TP# mutations 58 causative mutations 58 EGFR tyrosine kinase inhibitors 58 HGPIN 58 chromosomal rearrangement 58 COMT gene 58 prognostic indicators 58 renal carcinoma 58 specific antigen PSA 58 CDH1 58 premalignant lesions 58 PTP1B 58 IgG antibodies 58 trastuzumab Herceptin ® 58 genotypic resistance 58 melanocyte stimulating hormone 58 haematopoietic 58 FDG PET 58 clade B 57 Her-2/neu 57 bone metastasis 57 Epstein Barr virus EBV 57 micronuclei 57 EphB4 57 mucinous 57 nucleotide substitutions 57 ADAMTS# 57 IGF2 57 VEGF expression 57 IL 1ß 57 progranulin gene 57 PITX2 57 PI3K Akt 57 Cyclin D1 57 uPA 57 transrectal ultrasound 57 pulmonary metastases 57 Endometrial 57 BCR ABL 57 Sanger sequencing 57 antitumor immune 57 precancer 57 Skp2 57 hormone receptor status 57 histone modification 57 PKCi 57 ovarian endometrial 57 osteosarcomas 57 immunohistochemical staining 57 sarcosine 57 #S rRNA gene 57 SHANK3 57 BRAF V#E 57 estrogen receptor alpha 57 endometrial hyperplasia 57 radiosensitivity 57 suppressor gene 57 karyotype 57 HOTAIR 57 IDH1 57 MnSOD 57 pyruvate kinase 57 miR #b [001] 57 occult metastases 57 myeloma cells 57 transabdominal 57 prognostic biomarker 57 ErbB2 57 EGFr 57 KRAS BRAF 57 axillary dissection 57 situ hybridization 57 breast tumors 57 ZNF# 57 aCGH 57 Papillary 57 NMP# 57 antiproliferative effects 57 hamartomas 57 cathepsins 57 intracellular bacteria 57 p#INK#a 57 troponins 57 DNA methylation patterns 57 4E BP1 57 replicon 57 precancerous condition 57 CYP#D# genotype 57 HLA alleles 57 diagnostic biomarker 57 gastric carcinoma 57 replicase 57 florbetaben 57 histone modifications 57 microarray experiments 57 splice variant 57 prion infection 57 fetal chromosomal 57 transrectal ultrasound guided 57 human leukocyte antigens 57 causal variants 57 mouse neural stem 57 impair fertility 57 TH# cells 57 CXCL5 57 resistin 57 EGFR mutant 57 circulating endothelial cells 57 metastatic neuroendocrine tumors 57 node metastases 57 herpesviruses 57 alpha fetoprotein AFP 57 MLL2 57 cytokeratin 57 perineural invasion 57 colorectal neoplasms 57 predictive biomarker 57 carcinoembryonic antigen 57 endometrial 57 imatinib therapy 57 HIV tropism 57 transfected cells 57 mammary cells 57 cells CTCs 57 CYP#C# [002] 57 non coding RNA 57 NFkB 57 serologic testing 57 thyrotropin 57 tryptase 57 protein encoded 57 plasma kallikrein 57 Cytogenetic 57 KIAA# 57 imprinted genes 57 Single Nucleotide Polymorphisms SNPs 57 nucleic acid sequence 57 RKIP 57 thyroid stimulating hormone 57 TGF beta pathway 57 recurrent glioblastoma multiforme 57 mutated BRAF gene 57 ImmuKnow 57 SCN5A 57 aneuploid 57 vWF 57 autoantibody 57 lung adenocarcinoma 57 human leukocyte antigen 57 androgen receptors 57 ERK pathway 57 tyrosine phosphorylation 57 IFNg 57 TNFalpha 57 anti angiogenic drugs 57 mammary cancers 57 NGAL 57 situ hybridisation 57 microvessel density 57 ELISPOT 57 mammographic density 57 LIS1 57 oncogenic transformation 57 miRNAs 57 GIST tumors 57 pancreatic endocrine 57 gene BRCA2 57 colorectal polyp 57 thymosin 57 serologic 57 caveolin 1 57 epigenetic modifications 57 serotonin receptor 57 Oncotype 57 mosaicism 57 p#NTR 57 antibody mediated 57 histologic 57 neoplastic cells 57 MET amplification 57 nonsmall cell lung cancer 57 neoplastic 57 anterior pituitary 57 lymphovascular invasion 57 poor metabolizers 57 reverse transcriptase enzyme 57 anti apoptotic proteins 57 colorectal carcinomas 57 PTEN protein 57 MUC1 57 germline mutation 57 molecular biomarkers 57 mutant alleles 57 EpCAM 57 imatinib Gleevec 57 soluble receptor 57 SMN1 gene 57 haptoglobin 57 comparative genomic hybridization 57 metastatic lesions 57 microglial 57 ALK gene 57 Bezielle 57 oesophageal adenocarcinoma 57 miRview squamous 57 stratifying patients 57 collagen VII 57 globin 57 IGFBP2 57 oncoproteins 57 BRCA2 gene 57 progesterone receptor PR 57 effector functions 57 hormone deprivation 57 Squamous 57 intact parathyroid hormone 57 precancers 57 hypoxic tumor 57 ELISpot 57 HLA molecules 57 c MYC 57 number variants CNVs 57 Vpu 57 premalignant 57 Cytotoxic T 57 lymphoid tissue 57 GSTT1 56 molecular subtypes 56 M. pneumoniae 56 protein isoforms 56 tumor cells 56 EBNA1 56 Septin 9 56 RNA transcripts 56 mutant BRAF 56 nestin 56 mammary stem cells 56 MAGE A3 ASCI 56 lactate dehydrogenase 56 B7 H4 56 HNSCC 56 Histologic 56 N. gonorrhoeae 56 MGUS 56 transgenic rats 56 progesterone receptor negative 56 hCG beta 56 alternatively spliced 56 F FDG PET 56 metastatic tumors 56 immunohistochemistry IHC 56 trastuzumab Herceptin 56 transcriptional profiles 56 tumor recurrence 56 granulocytes 56 operable breast cancer 56 thymidylate synthase 56 P cadherin 56 granulosa cell 56 NKT cells 56 CLL cells 56 sentinel lymph node biopsy 56 synovial cells 56 antiangiogenic 56 mutated genes 56 DICER1 gene 56 ovarian malignancy 56 S. maltophilia 56 lymphatic tissue 56 genomic deletions 56 p# gene 56 E4 variant 56 endoxifen 56 RNA ribonucleic acid 56 endoglin 56 HER2 positive 56 taxane therapy 56 GnRH agonists 56 CD#c 56 RQ PCR 56 PARP inhibitor 56 neutralizing antibody responses 56 RPE# gene 56 inhibit angiogenesis 56 HERmark 56 NR#A# 56 RAR beta 56 PALB2 gene 56 FDG-PET/CT 56 BRCA mutation carriers 56 GSTM1 gene 56 sFlt1 56 pleiotrophin 56 prostate cancer PCa 56 histone acetylation 56 perfusion MRI 56 LKB1 56 sentinel lymph nodes 56 c Myb 56 coding genes 56 c KIT 56 K RAS 56 thyroid nodules 56 olfactory receptor 56 eTag assays 56 adenoma 56 PDGFR 56 inhibit replication 56 MYH9 gene 56 adipogenic 56 malignant ascites 56 prostate cancer metastases 56 ribosomal RNA rRNA 56 BMPR2 56 FUS protein 56 hepatocellular carcinomas 56 ano genital warts 56 BRCA mutation 56 genotypic 56 VEGFR2 56 RUNX3 56 biochemical marker 56 hematopoietic cancers 56 TNFa 56 ncRNAs 56 CD8 cells 56 syngeneic 56 beta subunit 56 Raf MEK ERK 56 HBx 56 LRP6 56 NQO1 56 multigene expression test 56 metastatic malignant 56 endothelial progenitor cells 56 CD8 responses 56 gamma interferon 56 IDH1 mutation 56 chitinase 56 adenocarcinomas 56 #S rRNA 56 NKX#.# 56 FDG PET scans 56 medulloblastomas 56 genotoxic stress 56 LTBI 56 molecularly targeted 56 #p# [001] 56 TP# mutation 56 mutant allele 56 miRNA profiling 56 noncancerous cells 56 SATB1 56 IgM antibodies 56 ERa 56 C. pneumoniae 56 p# MAPK 56 myogenic 56 serum antibody 56 tumoral 56 transthyretin 56 HG PIN 56 OncoVEX GM CSF 56 5 hmC 56 genes CYP#C# 56 factor receptor EGFR 56 NF kappaB 56 mediastinoscopy 56 viral genome 56 JAK2 56 sestamibi 56 viral proteins 56 Heterozygous 56 engineered RAP peptides 56 IFN beta 56 histopathological 56 Trichomonas vaginalis 56 serous ovarian cancer 56 alpha synuclein gene 56 ApoE4 56 EGFR expression 56 recurrent metastatic 56 telomerase inhibition 56 globin genes 56 miRview TM mets 56 p# Shc 56 nodal dissection 56 Dpp 56 cardiac troponin 56 CD# protein 56 Prox1 56 MAGE A3 protein 56 VNTR 56 ANGPTL4 56 PDE#A 56 HER2 positive breast 56 Mdm2 56 primary cilia 56 MDM2 56 androgen receptor 56 peritoneal carcinomatosis 56 neoadjuvant chemotherapy 56 estrogen receptors 56 oncogenic HPV types 56 differentially expressed genes 56 Akt3 56 flavopiridol 56 tumor suppressor protein 56 metastatic lesion 56 tumor histology 56 glycan 56 IDH mutations 56 #q# deletion 56 Jhdm2a 56 pelvic lymphadenectomy 56 M2 subunit 56 BCR ABL protein 56 mutated KRAS 56 BRCA mutations 56 HLA DR 56 adrenocortical 56 prostate tissue 56 anaplastic lymphoma kinase ALK 56 epigenetically 56 recurrent ovarian 56 antiangiogenic agent 56 hypermethylation 56 prognostic significance 56 pilocytic astrocytomas 56 p# deficient 56 telomerase activation 56 immunopathology 56 druggable targets 56 costimulatory 56 troponin T 56 glucocorticoid receptor 56 CIN3 56 hepatoma 56 Oncotype DX breast cancer 56 Darapladib 56 Histopathologic examination 56 histopathologic 56 atherosclerotic lesions 56 pelvic lymph nodes 56 cytological 56 MUC1 * 56 chromosome aberrations 56 immunochemical 56 epigenetic changes 56 metachronous 56 HCV replication 56 ras gene 56 pelvic malignancies 56 morphologic 56 cytomegalovirus CMV 56 CD# upregulation 56 C1q 56 incidentalomas 56 deCODE BreastCancer TM 56 salpingo oophorectomy 56 mammographic 56 HLA DQ 56 MLH1 56 mutational status 56 PCR assay 56 CMV infections 56 GBMs 56 myeloperoxidase 56 M. genitalium 56 MAP#K# 56 cytogenic 56 aromatase 56 acid phosphatase PAP 56 CD# receptor 56 humoral responses 56 Nedd4 56 RNA polymerases 56 Zolinza 56 segmental duplications 56 CXCR4 56 PI3K AKT 56 transmembrane receptor 56 cyclooxygenase 56 radioimmunotherapy RIT 56 RhD 56 leukemic stem cells 56 VIPR2 56 situ hybridization FISH 56 DFMO 56 angiogenesis inhibitor 56 HER2 amplification 56 homodimer 56 TIMP 56 obstructive coronary artery 56 Smac mimetic 55 underwent surgical resection 55 MC1R 55 uveal melanoma 55 FCGR3A 55 DNMT1 55 FMR1 gene 55 ApoE gene 55 SNP rs# [002] 55 pancreatic adenocarcinoma 55 FOXP3 55 K#R [002] 55 HDAC2 55 GRP# 55 CYP# [002] 55 Notch1 55 putative biomarkers 55 ribonucleic acid RNA 55 lung tumors 55 BALB c mice 55 APOE4 55 NRTI resistance 55 de novo mutations 55 mutated BRCA1 55 FOXO3a 55 IL #R 55 carcinoid 55 periodontal pathogens 55 immunocompetent 55 hypervascular 55 seropositive patients 55 isotype 55 miRs 55 C#Y mutation 55 mutant SOD1 55 palladin 55 histological examination 55 HIV HCV coinfected 55 Cervista HPV HR 55 scintigraphic 55 HER2 receptors 55 LRAT 55 prostate tumor 55 DNA methyltransferases 55 HER2 ErbB2 55 alkylating agents 55 malignant prostate 55 fibrocytes 55 micro RNA 55 A. phagocytophilum 55 atypia 55 downstream effectors 55 lymphocytic 55 testicular germ cell 55 KIF6 gene 55 rs# [002] 55 NPM1 mutation 55 ALDH 55 tumors 55 Brd4 55 induced sputum 55 generalized vitiligo 55 vitamin D receptor 55 DEAR1 55 castrate resistant 55 HLA DRB1 * 55 genes encoding 55 Leydig cells 55 PlGF 55 APOE e4 gene 55 antisense oligonucleotides 55 missense mutations 55 CYP#C# genotype 55 RNA splicing 55 NR#A# gene 55 carotid bruit 55 HLA antibody 55 mesenteric 55 HMGA2 gene 55 histone deacetylases 55 FMR1 55 CCR5 delta# 55 malaria parasite Plasmodium falciparum 55 follistatin 55 GABAergic neurons 55 ovarian carcinoma 55 leukocyte recruitment